Thomas Schlegl

Thomas Schlegl

Auto-generated profile, based on publicly available information

Thomas Schlegl

Medizinische Univ. Wien (Austria)

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2017
Verified
Book Chapter
Closed access
PDF file
TSThomas Schlegl
Thomas Schlegl
PSPhilipp Seeböck
Philipp Seeböck
SWSebastian M. Waldstein
Sebastian M. Waldstein
USUrsula Schmidt-Erfurth
Ursula Schmidt-Erfurth
GLGeorg Langs
Georg Langs

1 May 2019 in Medical Image Analysis
Verified
Journal Article
Closed access
TSThomas Schlegl
Thomas Schlegl
PSPhilipp Seeböck
Philipp Seeböck
SWSebastian M. Waldstein
Sebastian M. Waldstein
GLGeorg Langs
Georg Langs
USUrsula Schmidt-Erfurth
Ursula Schmidt-Erfurth

1 April 2018 in Ophthalmology
Verified
Journal Article
Open access
TSThomas Schlegl
Thomas Schlegl
SWSebastian M. Waldstein
Sebastian M. Waldstein
HBHrvoje Bogunović
Hrvoje Bogunović
FEFranz Endstraßer
Franz Endstraßer
ASAmir Sadeghipour
Amir Sadeghipour
USUrsula Schmidt-Erfurth
Ursula Schmidt-Erfurth
Development and validation of a fully automated method to detect and quantify macular fluid in conventional OCT images. Development of a diagnostic modality. The clinical dataset for fluid detection consisted of 1200 OCT volumes of patients with neovascular age-related macular degeneration (AMD, n = 400), diabetic macular edema (DME, n = 400), or retinal vein occlusion (RVO, n = 400) acquired with Zeiss Cirrus (Carl Zeiss Meditec, Dublin, CA) (n = 600) or Heidelberg Spectralis (Heidelberg Engineering, Heidelberg, Germany) (n = 600) OCT devices. A method based on deep learning to automatically detect and quantify intraretinal cystoid fluid (IRC) and subretinal fluid (SRF) was developed. The performance of the algorithm in accurately identifying fluid localization and extent was evaluated against a manual consensus reading of 2 masked reading center graders. Performance of a fully automated method to accurately detect, differentiate, and quantify intraretinal and SRF using area under the receiver operating characteristics curves, precision, and recall. The newly designed, fully automated diagnostic method based on deep learning achieved optimal accuracy for the detection and quantification of IRC for all 3 macular pathologies with a mean accuracy (AUC) of 0.94 (range, 0.91-0.97), a mean precision of 0.91, and a mean recall of 0.84. The detection and measurement of SRF were also highly accurate with an AUC of 0.92 (range, 0.86-0.98), a mean precision of 0.61, and a mean recall of 0.81, with superior performance in neovascular AMD and RVO compared with DME, which was represented rarely in the population studied. High linear correlation was confirmed between automated and manual fluid localization and quantification, yielding an average Pearson's correlation coefficient of 0.90 for IRC and of 0.96 for SRF. Deep learning in retinal image analysis achieves excellent accuracy for the differential detection of retinal fluid types across the most prevalent exudative macular diseases and OCT devices. Furthermore, quantification of fluid achieves a high level of concordance with manual expert assessment. Fully automated analysis of retinal OCT images from clinical routine provides a promising horizon in improving accuracy and reliability of retinal diagnosis for research and clinical practice in ophthalmology.

31 May 2019 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Closed access
PSPhilipp Seebock
Philipp Seebock
JOJose Ignacio Orlando
Jose Ignacio Orlando
TSThomas Schlegl
Thomas Schlegl
SWSebastian M. Waldstein
Sebastian M. Waldstein
HBHrvoje Bogunović
Hrvoje Bogunović
USUrsula Schmidt-Erfurth
Ursula Schmidt-Erfurth
Diagnosis and treatment guidance are aided by detecting relevant biomarkers in medical images. Although supervised deep learning can perform accurate segmentation of pathological areas, it is limited by requiring a-priori definitions of these regions, large-scale annotations, and a representative patient cohort in the training set. In contrast, anomaly detection is not limited to specific definitions of pathologies and allows for training on healthy samples without annotation. Anomalous regions can then serve as candidates for biomarker discovery. Knowledge about normal anatomical structure brings implicit information for detecting anomalies. We propose to take advantage of this property using bayesian deep learning, based on the assumption that epistemic uncertainties will correlate with anatomical deviations from a normal training set. A Bayesian UNet is trained on a well-defined healthy environment using weak labels of healthy anatomy produced by existing methods. At test time, we capture epistemic uncertainty estimates of our model using Monte Carlo dropout. A novel post-processing technique is then applied to exploit these estimates and transfer their layered appearance to smooth blob-shaped segmentations of the anomalies. We experimentally validated this approach in retinal optical coherence tomography (OCT) images, using weak labels of retinal layers. Our method achieved a Dice index of 0.789 in an independent anomaly test set of age-related macular degeneration (AMD) cases. The resulting segmentations allowed very high accuracy for separating healthy and diseased cases with late wet AMD, dry geographic atrophy (GA), diabetic macular edema (DME) and retinal vein occlusion (RVO). Finally, we qualitatively observed that our approach can also detect other deviations in normal scans such as cut edge artifacts.

1 June 2017 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
HBHrvoje Bogunović
Hrvoje Bogunović
SWSebastian M. Waldstein
Sebastian M. Waldstein
TSThomas Schlegl
Thomas Schlegl
GLGeorg Langs
Georg Langs
ASAmir Sadeghipour
Amir Sadeghipour
USUrsula Schmidt-Erfurth
Ursula Schmidt-Erfurth
Purpose: The purpose of this study was to predict low and high anti-VEGF injection requirements during a pro re nata (PRN) treatment, based on sets of optical coherence tomography (OCT) images acquired during the initiation phase in neovascular AMD. Methods: Two-year clinical trial data of subjects receiving PRN ranibizumab according to protocol specified criteria in the HARBOR study after three initial monthly injections were included. OCT images were analyzed at baseline, month 1, and month 2. Quantitative spatio-temporal features computed from automated segmentation of retinal layers and fluid-filled regions were used to describe the macular microstructure. In addition, best-corrected visual acuity and demographic characteristics were included. Patients were grouped into low and high treatment categories based on first and third quartile, respectively. Random forest classification was used to learn and predict treatment categories and was evaluated with cross-validation. Results: Of 317 evaluable subjects, 71 patients presented low (≤5), 176 medium, and 70 high (≥16) injection requirements during the PRN maintenance phase from month 3 to month 23. Classification of low and high treatment requirement subgroups demonstrated an area under the receiver operating characteristic curve of 0.7 and 0.77, respectively. The most relevant feature for prediction was subretinal fluid volume in the central 3 mm, with the highest predictive values at month 2. Conclusions: We proposed and evaluated a machine learning methodology to predict anti-VEGF treatment needs from OCT scans taken during treatment initiation. The results of this pilot study are an important step toward image-guided prediction of treatment intervals in the management of neovascular AMD.

22 October 2018 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Closed access
PSPhilipp Seebock
Philipp Seebock
SWSebastian M. Waldstein
Sebastian M. Waldstein
SKSophie Klimscha
Sophie Klimscha
HBHrvoje Bogunović
Hrvoje Bogunović
TSThomas Schlegl
Thomas Schlegl
GLGeorg Langs
Georg Langs
The identification and quantification of markers in medical images is critical for diagnosis, prognosis, and disease management. Supervised machine learning enables the detection and exploitation of findings that are known a priori after annotation of training examples by experts. However, supervision does not scale well, due to the amount of necessary training examples, and the limitation of the marker vocabulary to known entities. In this proof-of-concept study, we propose unsupervised identification of anomalies as candidates for markers in retinal Optical Coherence Tomography (OCT) imaging data without a constraint to a priori definitions. We identify and categorize marker candidates occurring frequently in the data, and demonstrate that these markers show predictive value in the task of detecting disease. A careful qualitative analysis of the identified data driven markers reveals how their quantifiable occurrence aligns with our current understanding of disease course, in early- and late age-related macular degeneration (AMD) patients. A multiscale deep denoising autoencoder is trained on healthy images, and a one-class support vector machine identifies anomalies in new data. Clustering in the anomalies identifies stable categories. Using these markers to classify healthy-, early AMD- and late AMD cases yields an accuracy of 81.40%. In a second binary classification experiment on a publicly available data set (healthy vs. intermediate AMD) the model achieves an AUC of 0.944.